Company Overview and News

10
AltaGas: Abandoning Canada, Will The Company Win Over U.S. Investors?

2018-09-17 seekingalpha
AltaGas has been consistently investing in U.S. projects over Canadian ones. Recent divestitures to fund the U.S. based WGL Holdings acquisition have tilted Canadian.
SOJA DUKH SO TRP SCG WGL DTK DUK ENB ENB ATGFF EQT WMB TRP ED PBA

11
6 Monthly Dividend Stocks to Buy

2018-09-14 investorplace - 1
Most dividend stocks pay their shareholders quarterly, but a few dividend yielding stocks offer monthly distributions.
SJR.B WBA LTC SJRWF OPRF SJR.A KMI PAA KMR STAG CVB APLE O SJR FDX MAR HLT PBA KMRFZ

1
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-09-07 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

13
Midstream Out Of Office Washout

2018-09-02 seekingalpha
Midstream had a rough week, the worst since late March and 4th worst so far this year. Oil prices rallied for a second straight week, NGL prices were sharply higher, the broad stock market was higher again, but midstream and MLPs lagged badly.
NGL CCR TGE ENB CEQP GNE EQM KMI TRP WMB AMGP OKE ED KMR CVB GEL NEE TRP VLP RGCO ENB ETP GNE TRGP PBA KMRFZ

17
Big Changes This Summer, Little Changed This Week

2018-08-27 seekingalpha
This week, Midstream stocks were little changed and basically kept pace with the S&P 500, which hit a new all-time high for the first time since January. Midstream stocks didn't get additional lift from the first positive week for oil prices in two months, but it certainly didn't hurt. Trading volume was light across midstream, with a few exceptions, and should be even lighter next week.
TGE CQP ENB WGP IPL SEP HCLP CEQP OKE.WI KMI TRP WMB EQGP AMGP EBBNF OKE KMR FGP IPPLF CVB ENBBF TRP GEIG ENB GMLP SEMG TRGP PBA KMRFZ

10
Targa Resources: Setting Up For A Move Higher

2018-08-24 seekingalpha - 2
Targa Resources Corp. (TRGP) is seeing its share price reverse higher after years of decline due to strengthening fundamental operations. Rising energy commodity prices are leading to stronger volume growth, benefiting Targa’s top line results. Moreover, the company continues to invest in new areas of growth, while seeing its newly started projects off to an early success. The company continues to issue debt, but maintains a strong balance sheet due to operational expansion.
CQP LNG WGP TRGP PBA

 
PBA: Latest Earnings Show Growth Story Continuing To Play Out

2018-08-16 seekingalpha
Pembina showed very strong year-over-year growth due largely to record volumes of commodities moving through its system.
PBA

 
This 7% Yielding Midstream Offers Compelling Long-Term Value

2018-08-14 seekingalpha
Stock is now our favorite in the Canadian midstream sector and offers even US investors a superb, non K-1, yield.
IPPLF PBA IPL

6
Midstream Rally Secured

2018-08-12 seekingalpha
Midstream traded up for a 6th straight week, with MLPs again out front with a 2.2% total return. The MLP Index's YTD total return is now nearly 12% after being negative less than a month ago. The broad market struggled a bit, and midstream was a safe place to hide on Friday when the broad market sold off on Turkey's currency plunge.
KAAC APA KEYUF XOM SMLP IPL GBNXF EQT KMI EQGP PAA KMR PBA NFG IPPLF CVB KMRFZ FANG

 
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-08-09 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

 
Navigator Holdings Ltd. (NVGS) CEO David Butters on Q2 2018 Results - Earnings Call Transcript

2018-08-07 seekingalpha
Thank you for standing-by, ladies and gentlemen and welcome to the Navigator Holdings Conference Call on the Second Quarter 2018 Financial Results.
NVGS MS PBA

2
Midstream Feeling The Flow

2018-08-06 seekingalpha
Midstream made gains for a 5th straight week, again led by MLPs. It was the best week for the MLP Index since January 2017. Good vibes and momentum carried through from last week with strong results from EPD, OKE and ENB among others, punctuated by the earlier than expected ETE/ETP simplification. After this week's move, the MLP Index has produced total return of 11.3% since June 25th.
ENB TRP KEYUF TRP ENB PBA IPPLF IPL

 
Pembina Pipeline Corp. 2018 Q2 - Results - Earnings Call Slides

2018-08-03 seekingalpha
The following slide deck was published by Pembina Pipeline Corp. in conjunction with their 2018 Q2 earnings call.
PBA

 
Pembina Pipeline Corp (PBA) CEO Michael Dilger on Q2 2018 Results - Earnings Call Transcript

2018-08-03 seekingalpha
Good evening, my name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Pembina Pipeline Corporation 2018 Second Quarter Results Conference Call. [Operator Instructions]. Thank you.
PBA

 
PBA / Pembina Pipeline Corp. FORM 6-K (Current Report of Foreign Issuer)

2018-08-02 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PBA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 706327103